Pérez Belmonte, L. M., Torres Peña, J. D., López Carmona, M. D., Ayala Gutiérrez, M. d. M., Fuentes Jiménez, F., Jorge Huerta, L., . . . Network, S. (2020). Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: A nationwide cohort study.
Citación estilo ChicagoPérez Belmonte, Luis M., et al. Mortality and Other Adverse Outcomes in Patients With Type 2 Diabetes Mellitus Admitted for COVID-19 in Association With Glucose-lowering Drugs: A Nationwide Cohort Study. 2020.
Cita MLAPérez Belmonte, Luis M., et al. Mortality and Other Adverse Outcomes in Patients With Type 2 Diabetes Mellitus Admitted for COVID-19 in Association With Glucose-lowering Drugs: A Nationwide Cohort Study. 2020.